Next-generation POC Devices for Western and Global Health Markets

About the Speaker
Samuel Sia is an Associate Professor in the Department of Biomedical Engineering at Columbia University. His lab focuses on using microfluidics for global health diagnostics and for 3D tissue biology. He is a founder of Claros Diagnostics, a venture capital-backed company developing diagnostics products which was acquired by Opko Health, and Harlem Biospace, New York City's first life-science incubatorAbstract
Portable diagnostic devices have a tremendous potential for revolutionizing personal health.  In U.S. and Europe, patients and consumers can have greater access to traditionally complex diagnostics, and in developing countries, mobile diagnostics provides immediate diagnosis in the field.  We will discuss our lab's current efforts in these areas, in conjunction with partners in industry, public health, and local governments.  Our tests span a variety of technologies, and target HIV, sexually transmitted diseases, and chronic diseases.